A Proposed System for Classifying Psychotropic Drugs
- 1 December 2014
- journal article
- review article
- Published by SLACK, Inc. in Journal of Psychosocial Nursing and Mental Health Services
- Vol. 52 (12) , 13-15
Abstract
Most drugs used in psychiatry are classified according to their initial or main therapeutic indications rather than by their pharmacological profiles. A proposed multi-axial, pharmacologically driven nomenclature system that would reclassify existing psychotropic drugs and provide a framework for classifying new drug compounds is described. The five axes of this system would describe a drug’s primary pharmacological target and relevant mechanism; relevant neurotransmitter and mechanism; neurobiological activities; efficacy and side effects; and approved indications. The proposed multi-axial system is a common sense but scientifically informed approach for classifying psychotropic drugs that would be practically useful for prescribers, clinicians, and patients. [ Journal of Psychosocial Nursing and Mental Health Services, 52 (12), 13–15.]Keywords
This publication has 7 references indexed in Scilit:
- Atypical Antipsychotics Are Not All Alike: Side Effects and Risk AssessmentJournal of Psychosocial Nursing and Mental Health Services, 2014
- A proposal for an updated neuropsychopharmacological nomenclatureEuropean Neuropsychopharmacology, 2014
- Mortality Risk of MirtazapineJAMA Psychiatry, 2014
- Off-Label Medication UseJournal of Psychosocial Nursing and Mental Health Services, 2012
- Understanding the Clinical Profile of a Drug on the Basis of Its Pharmacology: Mirtazapine as an ExampleJournal of Psychosocial Nursing and Mental Health Services, 2008
- Lisdexamfetamine: A Prodrug Stimulant for ADHDJournal of Psychosocial Nursing and Mental Health Services, 2008
- A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action statusHuman Psychopharmacology: Clinical and Experimental, 2006